Entering text into the input field will update the search result below

Vanda Pharmaceuticals beats by $0.35, beats on revenue

Oct. 27, 2014 7:17 AM ETVanda Pharmaceuticals Inc. (VNDA) StockBy: Mohit Manghnani, SA News Editor
  • Vanda Pharmaceuticals (NASDAQ:VNDA): Q3 EPS of -$0.04 beats by $0.35.
  • Revenue of $14.8M (+69.9% Y/Y) beats by $2.6M.
  • Press Release

Recommended For You

More Trending News

About VNDA Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
VNDA--
Vanda Pharmaceuticals Inc.